Inavolisib & EnzalutamideA Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor:

Hoffmann-La Roche

Code:

NCT07287150

Conditions

Metastatic Castration-Resistant Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Inavolisib

Enzalutamide

Abiraterone

Docetaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-20. This information was provided to ClinicalTrials.gov by Hoffmann-La Roche on 2026-08-05.